In this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.
For the first time in decades, inflation is in the headlines, and its impact is being felt throughout the US economy and household budgets. Affordability has been a challenge in health care for decades, and now the issue is magnified with across-the-board price increases inside and outside the industry.
According to PwC’s Health Research Institute, health care inflation hit 6.5% in 2022. In January 2023, the US Bureau of Labor Statistics released its Consumer Price Index 2022 review, showing percentage increases from December 2021 to December 2022. Prices for medical care and hospital and related services all rose more then 4%, and health insurance rose nearly 8%.
However, inflation overall eased a bit in December, although that is just a single month. What 2023 will look like—a soft landing or a broader, steeper fall into an economic slowdown—is still being scrutinized.
The truth is, government can’t wave a legislative wand to curb all the effects of inflation; and there isn’t a whole lot policy makers can do to halt rapidly rising prices. In health care, payers, providers and patients must work together to bring costs down.
For better or worse, the health care industry has been dealing with inflationary pressures for many years, with the rising costs for specialty prescription drugs, new technologies for diagnosis and treatment, and ever-increasing demand, particularly among an aging population.
We have to work together to curb inflation on two important fronts: moving past the traditional fee-for-service payment model and expanding the health care workforce to meet the growing demand for care.
We need a system that rewards health care providers for keeping patients healthy instead of simply treating them when they’re sick. Unlike fee-for-service, a “value-based” model focuses on prevention and wellness care, addressing health issues before they become chronic and costly; it offers patients a more coordinated health care experience, integrating mental health care into primary care; and it rewards providers for meeting cost efficiency and quality metrics.
Here in my state, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) launched Blue Premier in 2019, a payment model that now includes 11 of the state’s largest health systems. The first 3 years of Blue Premier generated nearly $500 million in savings, with corresponding increases in health outcome measures like increased colorectal screenings and blood pressure stability.
We’re pleased with our progress in moving away from fee-for-service to a more sustainable system. In the long run, savings derived from value-based care and other cost-containment measures likely won’t be sustainable without industry-wide investment in building the capacity of the health care workforce.
North Carolina was already facing a nursing shortage well before the more recent nurse exodus of the COVID period. And a study by the University of North Carolina’s Cecil G. Sheps Center for Health Services Research notes that the problem in our state is only getting worse. Over the next decade, North Carolina will face an estimated shortage of more than 12,000 registered nurses. The shortage of licensed practical nurses will be even more pronounced.
The health care industry must invest in its workforce – a short-term cost that will bring long-term results in the form of lower overall health care spending. Expanding the capacity of providers to meet the demand for health care will mean more patients are able to get the prevention and wellness care that can prevent chronic, costly health problems.
We need to slow the increase in demand for care and we need more practitioners to meet the demand for care. Embracing a value-based payment system and investing in expand the health care workforce are two important ways to blunt the impact of inflation. And we can’t afford to wait any longer.
Mitch Perry is senior vice president and chief financial officer (CFO) of Blue Cross and Blue Shield of North Carolina and is responsible for financial services, treasury, investment management, tax, financial and business planning, cost management, workplace resources, and strategic sourcing. He has been CFO since April 2016. Perry joined Blue Cross and Blue Shield of North Carolina in 2012.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More